glp 1 agonist for prediabetes GLP-1 receptor agonists are transforming diabetes care by improving blood sugar control, supporting weight loss, and reducing cardiovascular risk when used appropriately. Evidence-based therapy selection, correct dosing, and patient counseling are GLP-1 receptor agonists in the
Description
Procedural factors such as ketamine use during the procedure have a known association with nausea and increased secretions, these additional factors may also contribute to increased risk of aspiration and when combined with GLP-1 RA use and RGC (Rosenbaum et al

A study conducted at the University Medical Centre Ljubljana in Slovenia followed 25 women with PCOS who were treated with semaglutide (1.0 mg weekly) and metformin for 16 weeks

Many women breastfeed for 12 months or longer

In 2022, the FDA approved tirzepatide for the treatment of T2DM

Can J Anaesth

They concluded in the pooled analysis of 5,325 randomized and exposed individuals that rates of depression (2.1 vs 2.1 events/100 person-years) through adverse event reporting were similarly low in liraglutide and placebo groups
